EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model

Philippe Collery, Chloe Prunier, Emilien Dosda, Jean Viallet, Adhikesavan Harikrishnan, Vijay Veena, Didier Desmaele

Anticancer Research · 2024

DOI: 10.21873/anticanres.16889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Philippe Collery und 6 weiteren Autor:innen. Beteiligte Einrichtung: Société de Coordination de Recherches Thérapeutiques, Algajola, France; philippe.collery@gmail.com. Hauptthemen laut MEDLINE: Rhenium, Triple Negative Breast Neoplasms, Antineoplastic Agents, Mammary Neoplasms, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Rhenium(I)-diselenoether (Re-diSe) is a promising anticancer agent composed of one rhenium and two selenium atoms. Its effectiveness was established in inhibiting cancer cells while maintaining low toxicity toward normal cells at a 5 μM dose for 120 hours in MDA-MB-231 cells. In MDA-MB-231 breast tumor-bearing mice, anti-tumor and anti-metastatic effects were observed at a 10 mg/kg dose. However, contradictory results were observed in the 4T1 breast cancer model, where a dose of 60 mg/kg had a pro-tumor effect. To address these discrepancies, the efficacy of Re-diSe at the effective 10 mg/kg dose was validated in a transplanted MDA-MB-231 breast tumor model using the chicken chorioallantoic membrane assay. MATERIALS AND METHODS: MDA-MB-231 cancer cells were xenografted onto the chicken chorioallantoic membrane (CAM), and daily drug administration was carried out for nine days at doses of 0.1, 1, and 10 mg/kg. At the study's conclusion, a standard histological analysis was conducted. RESULTS: The low dose of 0.1 mg/kg showed a significant reduction in tumor weights compared to controls. The 1 mg/kg dose resulted in an increased inflammation score but did not induce a significant difference in tumor weights compared to the 0.1 mg/kg dose. Notably, at the 10 mg/kg dose, six out of 11 treated embryos displayed no visible signs of tumors. These tumors exhibited extensive tumor necrosis and significant infiltration by inflammatory cells. CONCLUSION: In this particular model, the anticancer efficacy of Re-diSe was achieved at the low dose of 0.1 mg/kg. The higher dose of 10 mg/kg, while eliminating visible tumors, might have immune-mediated effects, as indicated by substantial tumor necrosis and infiltration by inflammatory cells. Overall, this study successfully demonstrated the effectiveness of Re-diSe as an anticancer agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RheniumTriple Negative Breast NeoplasmsAntineoplastic AgentsMammary Neoplasms, AnimalBreast NeoplasmsHumansChick EmbryoAnimalsMiceFemaleChickensNecrosisCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

Rheniumbreast cancerchicken embryo modeldose-effectinflammationselenium

Substanzen

RheniumAntineoplastic Agents

Autor:innen und Institutionen

  • Société de Coordination de Recherches Thérapeutiques, Algajola, France; philippe.collery@gmail.com.
  • Inovotion, La Tronche, France.
  • Department of Chemistry, School of Arts and Science, Vinayaka Missions Research Foundation (DU), Chennai, India.
  • School of Allied Healthcare and Sciences, Jain University, Bangalore, India; btveenavijaykumar@gmail.com.
  • Institut Galien, Orsay, France.

Zitieren

APA

Collery, P., Prunier, C., Dosda, E., Viallet, J., Harikrishnan, A., Veena, V., & Desmaele, D. (2024). Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model. Anticancer Research. https://doi.org/10.21873/anticanres.16889

Vancouver

Collery P, Prunier C, Dosda E, Viallet J, Harikrishnan A, Veena V, et al. Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model. Anticancer Research. 2024. doi:10.21873/anticanres.16889

BibTeX
@article{Collery2024,
  author = {Collery, Philippe and Prunier, Chloe and Dosda, Emilien and Viallet, Jean and Harikrishnan, Adhikesavan and Veena, Vijay and Desmaele, Didier},
  title = {Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16889}
}
Kostenlos starten →